Henry Schein Inc

HSIC remains in a Stage 2 advancing uptrend with a bullish medium-term bias, supported by rising EMAs and persistent HH/HL structure. However, the active Blow-Off Top pattern, exhaustion candles, and extreme overbought conditions signal waning near-term momentum. With price extended above the 9/21 EMAs, we defer execution and await a shallow pullback into dynamic support in line with our Free Cash Flow + Buybacks strategy.

• ↑U.S. dental merchandise revenue +5.6% YoY driven by DSO demand.
• ↑Targeting $200m annual operating income improvement via efficiency initiatives.
• ↓Q1 medical diagnostic revenue fell on respiratory test weakness.